Mark DeLong - Oct 20, 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Senior Vice President
Signature
/s/ David Watson, attorney-in-fact for Mark Delong
Stock symbol
APLS
Transactions as of
Oct 20, 2021
Transactions value $
$0
Form type
4
Date filed
10/27/2021, 04:26 PM
Previous filing
Jul 22, 2021
Next filing
Feb 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +882 +9.29% $0.00 10.4K Oct 20, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a restricted stock unit that vest 50% annually over two years from grant date, subject to continued service.